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Abstract
Chronic alcohol consumption is a prevalent phenomenon linked to many
behavioral constructs, including impulsivity and cognitive inflexibility, as well as
neuropathology in brain regions central to these tasks such as the orbitofrontal and
limbic cortices. The detrimental effects of alcohol consumption are due to a confluence
of factors that often occur in addition to alcoholism, importantly thiamine deficiency. This
nutritional deficiency can manifest in the amnestic disorder Wernicke-Korsakoff
Syndrome, most commonly seen in cases of alcoholism. In this study, we examined the
effects of chronic alcohol exposure and thiamine deficiency in isolation, as well as in
concert, to further our understanding of the independent effects of each treatment and
how they interact. Furthermore, we included a group receiving chronic alcohol with
thiamine supplementation to deduce whether the effects of long term alcohol exposure
can be ameliorated with prophylactic treatment. Our results demonstrated that both
chronic alcohol exposure and moderate thiamine deficiency induce an impulsive
phenotype. Importantly, the increased impulsivity induced by thiamine deficiency was
protracted as compared to that exhibited under conditions of chronic alcohol alone.
Additionally, there may be decreased cellular activity in the posterior orbitofrontal cortex
in chronically alcohol treated animals, as well as increased limbic cortical volume.
However, differential pathology was observed in the chronic ethanol treated group
presenting as increased limbic volume. This study has furthered our understanding of
iv

the role of multiple factors in alcohol induced decision making deficits while illustrating
the need to look at the interaction of chronic alcohol exposure induced mild thiamine
deficiency. It also provides justification to investigate potential prophylactic treatments for
alcoholics or those in treatment to prevent further neurological insult.
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Introduction
Alcohol consumption is ubiquitous across cultures. The lifetime prevalence of alcohol
use disorders in males is 8.4%, and 4.2% of females according to the Substance Abuse
and Mental Health Services Administration; additionally, 70.1% of the population
reported using alcohol within the past year (SAMHSA, 2015). It has been established
that chronic alcohol consumption can lead to brain damage.
The detrimental effects of chronic alcohol exposure are due to a confluence of
factors; not only does alcohol exposure alone induce cellular death and damage to
neural tissue (Goodlett and Horn, 2001), but there are also common comorbid factors
that cloud our ability to ascertain the effects of alcohol consumption in isolation. Chronic
compulsive alcohol consumption without a comorbid condition must be studied to
increase our understanding of alcohol’s damaging effects because alcoholism is often
‘complicated’ by the existence of other conditions such as liver disease, polydrug use,
history of head trauma, or nutritional deficiency (Pitel, Zahr, Jackson, Sassoon,
Rosenbloom, Pfefferbaum, and Sullivan, 2011; Sullivan and Pfefferbaum, 2005). It is
important to understand the effects of chronic alcohol exposure in addition to each of
these factors in isolation as well as the consequences of these common comorbidities in
and of themselves.
Chronic alcohol consumption alone has also been demonstrated in human
studies and animal models to elicit neuropathology due to a confluence of molecular
factors. Importantly, the most vulnerable regions include the orbitofrontal and cingulate
cortices, with volume loss again being an expression of pathology (for review see
Sullivan and Pfefferbaum, 2005; Volkow and Fowler, 2000; Ridderinkhof, Vlut,
Bramlage, Spaan, Elton, Snel, and Band, 2002). Alcohol exposure can lead to apoptosis
or necrosis (cell death), interfere with cellular function and alter cellular division rates,
1

depending on the type of cell and its developmental stage (for review see Goodlett and
Horn, 2001; Bredensen, 1996 a, b). As will be discussed below, thiamine deficiency may
also play a role in these processes.
As these studies have demonstrated, chronic alcohol consumption can be highly
detrimental to the integrity of the brain. Importantly, comorbid conditions can exacerbate
these effects, particularly nutritional deficiency. In the following section the effects of
thiamine deficiency, which can be induced by high levels of alcohol consumption, will be
explored.

Thiamine Deficiency in Alcoholism
The confluence of nutritional deficiency in alcoholism is of particular interest,
specifically in the case of thiamine deficiency, as this can result in Wernicke-Korsakoff
Syndrome (WKS). WKS is a retrograde and anterograde diencephalic amnesic disorder
most often seen in alcoholics, but also found in those with bulimia, gastrointestinal
distress, starvation, long term IV usage, dialysis and AIDS (for review Mair, 1994;
Kopelman, Thomson, Guerrini, and Marshall, 2009). Chronic alcoholics are prone to
nutritional deficiency because they derive up to 41% of their calories from alcohol
(Gruchow, Sobocinski, Barboriak, and Scheller, 1985). To further exacerbate this
situation, chronic alcohol consumption also decreases absorption or utilization of
nutrients (Galvin, Brathens, Ivashynka, Hillbom, Tanasescu, Leone, 2010) which may
result in, or compound, the effects of nutritional deficiency.
It is estimated that up to 80% of alcoholics are thiamine (vitamin B1) deficient due to
poor nutrition (Galvin et al., 2010), however, approximately 75% of cases of thiamine
deficiency are undiagnosed in alcoholics (for review see Zahr, Kaufman, and Harper,
2011) and around 13% of alcoholics have thiamine deficiency induced neuropathology
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(for review see Harper, Giles, and Finlay-Jones, 1986). There is also graded damage
between these groups; milder brain and behavioral dysfunction is seen in uncomplicated
alcoholics relative to complicated alcoholics with thiamine deficiency. (Pitel, et al., 2011;
Sullivan, and Pfefferbaum, 2005). Therefore, it is clear why WKS is seen in cases of
alcoholism.
Thiamine deficiency can induce excitotoxic lesions to the thalamus (anterior and
midline nuclei) and mammillary bodies which are a hallmark feature of the
neuropathology seen in WKS (de Wardener and Lennox, 1947). Thalamic lesions are
necessary to induce the amnestic disorder, however hippocampal damage is sometimes
observed as well (for review see Kopelman, Thomson, Guerrini, and Marshall, 2009;
Sullivan and Pfefferbaum, 2005). Additionally, frontal lobe atrophy, and white matter
pathology are often detected. Particularly relevant to this study is the fact that the most
vulnerable frontal regions include the orbitofrontal and cingulate cortices, which often
present with decreased overall volume, reduced neuronal density, and decreased
metabolism and blood flow (for review see Beaunieux, Eustache and Pitel, 2014;
Sullivan, and Pfefferbaum, 2005). In addition to amnesia, WKS patients also present
with impaired problem solving skills, poor content and contextual memory, deficits in
spatial learning and memory, ataxia, oculomotor disturbances, and global confusion (for
review see Savage, 2014; Savage, Hall, and Resende, 2012; Vetreno, Klintsova, and
Savage, 2011; Roland, Mark, Vetreno, and Savage, 2008; Vetreno, Hall and Savage,
2011; van Oort, and Kessels, 2009; Pitel, et al., 2011).
A contributing factor in chronic alcohol induced cell death may be due to
alterations in gastric motility, and nutritional absorption caused by alcohol consumption
(for review see Martin, Singleton, and Hiller-Sturmhofel, 2003; for review see Hoyumpa,
1980). Specifically, the B vitamin, thiamine has been implicated in cellular death when
3

depleted as will be discussed in the following paragraphs (for review see Butterworth,
2003).
As reviewed by Martin et al. (2003), adult Homo sapiens require >0.33 mg of
dietary thiamine per 1,000 calories consumed (0.66 mg per day given a 2,000 calorie
diet) (Hoympa, 1980; Martin et al. 2003). However, in alcoholics, oral absorption of
thiamine is minute to non-existent (Agabio, 2005; Thomson, 2000). Deficits in this
vitamin disrupt a variety of metabolic pathways and the synthesis of numerous
neurotransmitters and proteins.
Three enzyme systems are dependent on thiamine: transketolase, pyruvate
dehydrogenase, and alpha-ketoglutarate. Transketolase is involved in the pentose
phosphate pathway, which plays a role in myelination maintenance. Pyruvate
dehydrogenase plays a role in energy production via the breakdown of pyruvate to the
coenzyme Acetyl CoA, an enzyme also involved in the production of the
neurotransmitter acetylcholine. Finally, alpha-ketoglutarate, a glutaric acid is involved in
the formation of the neurotransmitters acetylcholine, GABA, and Glutamate (for review
see Martin et al, 2003; Cook, Hallwood, and Thomson, 1998; Thomson and Pratt, 1992;
Thomson, Jeyasingham, Pratt, and Shaw, 1986) as well as aspartate, another excitatory
neurotransmitter (Martin et al, 2003). Thiamine is, therefore, central to the preservation
of the myelin sheath, cellular energy reserves, and neurotransmitter synthesis. Based on
these findings one can see how thiamine deficiency can lead to neuronal dysregulation
on several fronts.
Adding fuel to the fire is the fact that thiamine deficiency also induces a selective
downregulation of the glutamate transporters located at the astrocyte/synapse junction
on the astrocytic cell in some brain regions (for review see Butterworth, 2003; Hazell,
Rao, Danbolt, Pow, and Butterworth, 2001; Sheldon, and Robinson, 2007) exacerbating
4

the potential for both alcohol and thiamine deficiency induced cellular death. As
discussed by Sheldon and Robinson (2007), extracellular metabolism of glutamate does
not seem to occur once it is released. As such, it must be removed from the synaptic
space by transporters, in this case by glutamate transporters (GLUTS) including GLT-1
and GLAST. These transporters are found on astrocytic processes proximal to the
synaptic terminal where they are in a prime position for glutamate uptake and storage
(for review see Sheldon and Robinson, 2007; Hazell et al., 2001). This down regulation
of GLUTs leads to an increase in extracellular glutamate (for review see Butterworth,
2003; Hazell et al., 2001). Due to the excitatory nature of glutamate, extracellular levels
need to be regulated to prevent excitotoxicity induced cell death. These observations
further implicate thiamine deficiency as a factor in the cell death induced by chronic
alcohol exposure.

Alcohol Addiction, Thiamine Deficiency, and Impulsivity
The propensity to consume excessive amounts of alcohol in addicted individuals,
which may contribute to thiamine deficiency, also has a genetic component that should
be considered. There is evidence that differential genetic backgrounds can alter
susceptibility to the thiamine deficiency inducing effects of chronic alcohol consumption.
Based on work by multiple researchers (for review see Martin et al., 2003; Tallaksen,
Bohmer, and Bell, 1992; Hoyumpa, 1980; and Morgan, 1982) it appears that as high as
80% of alcoholics may experience thiamine deficiency. However, as discussed by
Harper et al., (1988), only ~13% of this population develop WKS. This indicates that
there may be a subset of the population with a higher sensitivity to thiamine deficiency
that may be more vulnerable to alcohol induced thiamine deficiency related brain
damage (Harper, Gold, Rodriguez, and Perdices, 1989). Work investigating this point
5

has returned mixed results. For example, Mukherjee and colleagues (1987) observed
that both alcoholic men and their alcohol naive sons had lower levels of thiamine
diphosphate (metabolically active thiamine) than controls (Mukherjee, Svoronos,
Ghazanfari et al., 1987). However, another study found no differences in thiamine
diphosphate, indicating that there was not a difference in the transketolase enzyme
necessary to add the diphosphate bonds to thiamine and render it active (Nixon,
Kaczmarek, Tate, Kerr and Price, 1984). Because some work has demonstrated that
moderate thiamine deficiency increased white matter pathology in a genetic model with
alcohol exposure (He, Sullivan, Stankovic, Harper, and Pefferbaum, 2007), this opens
an avenue for further investigation applying a thiamine deficient protocol to genetic
models of addiction. Furthermore, the addiction phenotype includes pervasive executive
function deficits, which may be exacerbated by thiamine deficiency and alcohol
exposure, including impulse control deficits and perseverative behavior.
Persistent, compulsive drug use without regard to consequences is a hallmark
feature of addiction (for review see Hyman, Malenka and Nestler, 2006; for review see
Crews and Boettiger, 2009; Hser, Hoffman, Grella, and Anglin, 2001; McLellan, Lewis,
O’Brien, and Kleber, 2000). Although some regular users are able to abstain on their
own, for many addiction is a chronic problem (Hyman, Malenka and Nestler, 2006). This
compulsive behavior is related to deficits in reversal learning (Jentsch, Olausson, De La
Garza and Taylor, 2002), perseverative behavior (related to reversal learning) (Hyman,
2005), and impulsivity (for review see Jentsch and Taylor, 1999; Oberlin and Grahame,
2009; Crews and Boettiger, 2009) and has long been associated with addiction as
demonstrated by these animal models of drug exposure and genetic susceptibility as
well as human studies examining decision making in similar tasks.
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Executive Function Deficits: Impulsivity and Reversal Learning
Impulsivity is a maladaptive inability to delay receipt of reward resulting in a net
loss of reward (e.g. food, money) for the organism (Ainslie, 1975). Delay discounting
paradigms are a highly translational behavioral assessment of impulsive choice behavior
(referred to as impulsivity or impulsive choice here) contingent on the fact that the
preference for a large immediate reward over a small one is conserved between species
(Mazur, 1987; Oberlin and Grahame, 2009; Odum, 2011), and that as the wait to receive
the reward increases over time the perceived value of said reward subjectively
diminishes (Bechara, Dolan, and Hindes, 2002; Odum, 2011; Oberlin and Grahame,
2009; Mars and Robbins, 2007; Mazur, 1987), hence “Delay Discounting”.
Delay discounting can manifest as a maladaptive behavior leading to an inability
of the organism to optimize the results of goal directed behavior due to an inordinate
preference for small immediate gain regardless of the potential for overall long term gain
and greater overall rewards accrued (Ainslie, 1975). Because immediate rewards are
excessively valued during decision making, there is a tendency in some individuals to
quickly change their preferences and decision making styles to favor an immediate short
term reward over a deferred, but greater, reward (Mazur, 1987).
In populations with a genetic predisposition towards addiction, drug naive
impulsivity can be predictive of future drug consumption (Oberlin and Grahame, 2009;
Beckwith and Czachowski, 2014). However, drug exposure has also been demonstrated
to correlate with impulsivity. Beckwith and Czachowski (2014) demonstrated that high
‘alcohol seeking’, but not ‘consumption’, positively correlates with increased delay
discounting. This study used high alcohol drinking (HAD2) and alcohol-preferring (P)
rats, both genetic models of alcoholism. Interestingly, only the ‘high seeking’ P rats
demonstrated greater delay discounting than control Long-Evans rats, indicating that
7

there is a link between drug seeking and impulsivity that is independent of consumption
(Beckwith and Czachowski, 2014). Furthermore, P rats have also been shown to have
increased choice impulsivity (Perkel, Bentzley, Andrzejewski, and Martinetti, 2015
(alcohol naïve); Linsenbardt, Smoker, Janetsian-Fritz, and Lapish, 2016 (vs parent
strain)). Other rodent models selected for alcohol drinking have also exhibited
differences in impulsivity subtypes. For example, the high drinking STDRH12 mouse has
increased motor, but not choice, impulsivity (Wilhelm, Reeves, Philips, and Mitchell,
2007). These studies indicate that, although impulsivity plays a role in addiction, it is not
the only factor involved in the presentation of an addictive phenotype and that certain
types of impulsivity and drug ‘seeking’ or ‘consumption’ may have separable roles.
In human males with alcohol use disorders increased choice impulsivity is also
observed. Additionally, these subjects exhibited hyperactivity in brain regions related to
cognitive control and prospection; the dorsolateral prefrontal cortex and posterior parietal
cortex, respectively (Amlung, Sweet, Acker, Brown, and MacKillop, 2014). A study
examining females with alcoholism also demonstrated that there is increased choice
impulsivity as well as increased activity in multiple brain regions related to cognitive
control including the insula/orbitofrontal cortex (Claus, Kiehl, and Hutchison, 2011). This
finding is in line with studies demonstrating the roles of the medial and lateral
orbitofrontal cortex, anterior cingulate, and anterolateral prefrontal cortex in reward
dependent decision making (for review see Rushworth, Noonan, Boorman, Walton, and
Behrens, 2011, for OFC specific reviews see Wallis, 2007 and 2012). Another study,
examining women, found increased impulsivity in heavy drinkers as well as decreased
sensitivity to the aversive effects of alcohol consumption, which may increase abuse
potential (Reed, Levin, and Evans, 2012). Increased impulsivity is also seen in
numerous other addictive phenotypes ranging from nicotine use (Baker and Bickel,
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2003) to compulsive gambling (MacKillop, Anderson, Castelda, Mattson, and Donovick,
2006; MacKillop, Amlung, Few, Ray, Sweet, and Munaffo, 2011).
Additionally, alcohol exposure during development and adolescence may
increase impulsive choice behavior (Banuelos, Gilbert, Montgomery, Fincher, Wang,
Frye, Setlow, and Bizon, 2012) as well as relate to other associated behaviors such as
adolescent anxiety (Mejia-Toiber, Boutros, Markou, and Semanova, 2014; (Stein,
Renda, Barker, Liston, Shahan, and Madden, 2015) and risk taking (Roman, Stewart,
Bertholomey, Jensen, Colombo, Hyytia, Badia-Elder, Grahame, Li and Lumeng, 2012).
Other decision making deficits also appear to contribute to this behavioral phenotype.
Cognitive flexibility is also an executive function metric closely related to impulsivity and
governed by many of the same brain regions, as will be discussed below. Deficits in
cognitive flexibility, measured by reversal learning tasks, are also seen in models of
addiction and alcohol exposure.
Reversal learning tasks are another way to assess OFC function and evaluate
potential decision making deficits. Successful reversal learning requires reflection on
past stimulus-reward associations and the adaptation of behavior to accommodate
changing reward contingencies, which are considered an essential element of emotional
and social behavior. Reversal learning tasks examine both affective (emotion based)
decision making and learning, in addition to assessing the ability to alter behavioral
response when presented with changes in stimulus-reward associations (Franken, van
Strien, Nijs and Muris, 2008). Reversal learning is also used to assess both compulsive
and impulsive behavior, and OFC function in addiction (for review see Izquierdo and
Jentsch, 2012). Additionally, in the case of delay discounting tasks, reversal learning
may also be an inherent part of the task as the perception of the ‘preferred lever’ is
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altered with increasing delay, which may confound the discrimination between reversal
learning deficits and a propensity toward impulsive choice behavior.

Brain Regions Governing Impulsivity and Cognitive Flexibility
Impulsivity and cognitive flexibility are both governed largely by the orbitofrontal
cortex as has been demonstrated by numerous studies. For example, lesions to the
orbitofrontal cortex result in the inability of animals to modify their responding following
alterations in reward contingencies (Chudasama, Passetti, Rhodes, Lopian, Desai, and
Robbins, 2003; for review see Clark, Cools, and Robbins, 2004; Boulougouris, Dalley,
and Robbins, 2007) because this area encodes for violations of reward expectation, with
reversal responding supported by the lateral OFC specifically (Ghahremani, Monterosso,
Jentch, Bilder, and Poldrack, 2010). Damage to the OFC has been shown to lead to
impulsivity, behavioral inflexibility, and emotional disorder (Roberts and Wallis, 2000).
Loss of inhibitory control of affective responding has been implicated in impaired
reversal learning. Deficits may also present themselves as a failure to avoid short term
reward that leads to long term negative consequences (choice impulsivity) (Clark, Cools,
and Robbins, 2004). There is substantial evidence suggesting that there is orbitofrontal
dysfunction in addicts, which may contribute to compulsive behavior (Everitt, Belin,
Economidou, Pelloux, Dalley, and Robbins, 2008). In cases of frontotemporal dementia
with OFC pathology, compulsive behaviors have been reported including hyperphagia,
gambling, and substance abuse. OFC damage in humans, as well as non-human
primates and rodents, has led to addictive behavior (Crews and Boettiger, 2009).
Additionally, there is evidence from human neuroimaging studies, as well as animal
studies, examining cellular activity that corroborates these findings.
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Neuroimaging studies performed on healthy subjects have shown that the
prefrontal cortex is activated during reversal learning tasks, and that deficits in reversal
learning are correlated with damage to the OFC (Franken et al, 2008). The role of these
areas in reversal learning is further supported by studies recording the activity of single
cells in the orbitofrontal cortex, which have confirmed that the firing of neurons in this
region changes in response to alterations in reward contingencies. Importantly, neurons
in the macaque OFC have been shown to reverse from firing at the presentation of
previously rewarded stimulus to a currently rewarded stimulus (for review see Clark,
Cools, and Robbins, 2004; Rolls, Critchley, Mason, and Wakeman, 1996; Thorpe, Rolls,
and Maddison, 1983) implicating them in cognitive flexibility when reward contingencies
change.
Shoenbaum and colleagues have demonstrated that the orbitofrontal cortex
plays a particularly pivotal role in the assessment of expected and received outcomes
(for review see Shoenbaum, Roesch, and Stalnaker, 2006), important in decision making
tasks central to this study (delay discounting and reversal learning). Human
neuroimaging studies have demonstrated that there are changes in blood flow in the
OFC both while anticipating outcomes and when the expected outcome is altered or not
attained (Gottfried, O’Doherty, and Dolan, 2003; Gottfried, O’Doherty, and Dolan 2002;
O’Doherty, Deichman, Critchley, and Dolan, 2002; Nobre, Coull, Frith, and Mesulam,
1999). This change appears to be associated with reward value and is observed when
this information is being processed in decision making (Arana, Parkinson, Hinton,
Holland, Owen, and Roberts, 2003). Animal studies have demonstrated that the neurons
in the OFC fire differentially depending on reward salience including expected size, time
to attainment, and possible consequences of incorrect behavior (Schoenbaum, Stelow,
Saddoris, and Gallagher, 2003; Schoenbaum, Chiba, and Gallagher, 1998; Tremblay
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and Schultz, 1999; Roesch and Olson, 2004; Roesch and Olson, 2005) making them
critical in delay discounting tasks which require the assessment of reward size and time
to attainment. If an expected reward is not obtained, or is devalued (ex: by time), there is
a decrease in this responding (Tremblay, and Schultz, 1999). Thus, outcome
expectancies encoded by the OFC are critical to adaptive learning (Saddoris, Gallagher,
and Schoenbaum, 2005). Additionally, there is evidence that the maladaptive decision
making processes associated with drug addiction may result from drug induced changes
to this region (London, Ernst, Grant, Bonson, and Weinstein, 2000; Rogers, Everitt,
Baldacchino, Blackshaw, Swainson, Wynne, Baker, Hunter, Carthy, Booker, London,
Deakin, Sahakian, and Robbins, 1999; Porrino, and Lyons, 2000; for review see Dom,
Sabbe, Hulstiin, and Van Den Brink, 2005). This possibility indicates that an underlying
deficit in this behavior could be exacerbated by drug and alcohol exposure, as well as
thiamine deficiency.
The limbic cortex (infralimbic and prelimbic regions encompassing the medial
prefrontal cortex) is implicated in response inhibition, which also relates to an impulsive
phenotype as the organism’s inability to suppress the impulse to respond although it has
been learned that no reward can be elicited (Chudasama, Passetti, Rhodes, Lopain,
Desai, and Robbins, 2003). Studies have demonstrated that the limbic region is not
involved in successful reversal learning, however. These experiments have shown that
there is functional selectivity in this type of task. While the OFC and limbic cortices both
play a role in impulsivity, the OFC alone was implicated by these lesion studies
(Boulougouris, Dalley, Robbins, 2007).
Recent work in this lab, using an animal model, has demonstrated that thiamine
deficiency in conjunction with chronic ethanol exposure impaired cognitive flexibility. This
study used spontaneous alternation and attentional set shifting to assess this aspect of
12

executive function. Additionally, these results supported the potential that sub-clinical
thiamine deficiency may exacerbate the cognitive deficits induced by chronic alcohol
consumption (Vedder, Hall, Jabrouin, and Savage, 2015). Here, we further this line of
inquiry into executive function assessments and how this behavior can be altered by a
variety of treatments. We investigated the effects of chronic ethanol consumption,
thiamine deficiency, thiamine supplementation, and the combination of those variables
on behavioral tasks that are highly dependent on the frontal cortex. We assessed
impulsivity using an operant delay discounting task and incorporated a reversal of
reward contingencies to examine differences in impulsivity and cognitive flexibility
induced by these treatments. Following these tasks, we examined the neuropathology
induced by thiamine deficiency; thalamic cell loss using NeuN to stain neuronal cell
bodies. The immediate early gene Arc was then used to examine neuronal activity in the
OFC and infralimbic/prelimbic cortices. Additionally, Cavalieri volumetric analysis was
used in conjunction with NeuN staining to assess possible changes in the volume of the
OFC and limbic cortices. The results of this investigation allow us to further tease apart
the roles of the OFC and limbic cortices in impulsivity and cognitive flexibility as well as
the effects of alcohol exposure, thiamine deficiency, and the comorbid treatments on
these brain regions and the associated behavioral constructs.

Methods
Subjects
This experiment used 56 adult male Sprague-Dawley rats (Envigo, Indianapolis,
IN, USA) that where 3-4 months at the start of treatment. Rats were randomly assigned
to one of 6 treatment groups (see Vedder et al, 2015); Pair Fed (PF) control group;
Chronic Ethanol Treatment (CET); Chronic Ethanol Treatment with IP Thiamine
13

supplementation (CET-Th); Chronic Ethanol Treatment in conjunction with IP injections
of Pyrithiamine hydrobromide (CET-PTD); PTD-EAS (Pyrithiamine induced Thiamine
Deficiency-Early Acute Stage; and PTD-MAS (Pyrithiamine induced Thiamine
Deficiency-Middle Acute Stage). The initial N consisted of 8-9 per group, though some
subjects were lost due to failure to thrive post-treatment or advanced age resulting in a
final N of 48. Additionally, tissue damaged during processing resulted in the loss of some
subjects and varied group sizes in immunohistological assays. All experiments were
conducted according to the Committee for the Update of the Guide for the Care and Use
of Laboratory Animals (2011). All experimental protocols were approved by the
Institutional Animal Care and Use Committee at the State University of New York at
Binghamton.
Treatments
Chronic Ethanol Treatment: Ethanol treated groups (CET, CET-Th, CET-PTD)
were exposed to increasing concentrations of ethanol using a ‘Fading On’ procedure
during which subjects receive 6%, 9%, 12% and subsequently 20% ethanol in tap water
in five day increments. Following six months of 20% ethanol in tap water, animals were
titrated off using the reverse of this procedure, termed ‘Fading Off’. During ethanol
exposure, tail blood samples were taken and analyzed for blood ethanol concentration
(BEC) via ANALOX at month 1, 2/3, 4, and 6. Consumption was assessed twice a week
(by taking bottle weights) for these animals. PF animals also had their fluid consumption
(tap water) monitored and had blood samples taken at the above-mentioned times. CETTh subjects received IP injections of thiamine hydrochloride (0.4 mg/kg IP) three times a
week, in addition to chronic ethanol exposure, and had BECs taken at the same time as
samples were collected from other ethanol groups (Figure 1).
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Pyrithiamine-induced Thiamine Deficiency (TD): Thiamine deficient groups (CETPTD, PTD-EAS, and PTD-MAS) received ad libitum thiamine deficient chow (Envigo
Diets, IN, USA) and received daily injections of pyrithiamine hydrobromide, which
prevents thiamine from becoming metabolically active, (0.25 mg/kg IP; Sigma-Aldrich,
St. Louis, MO) beginning 1 month into ethanol exposure in CET treated groups. About
12-13 days after the start of PTD treatment neurological symptoms (anorexia, ataxia,
loss of righting reflexes, and ultimately opisthotonus (spasm) were recorded hourly. Rats
were treated to different severity levels of TD, consisting of: (i) an early acute stage
(PTD-EAS and CET-PTD) in which rats were reversed with a bolus of 0.5 cc of thiamine
hydrochloride (100 mg/ml, IP; Sigma-Aldrich) within 1 hour after the appearance of
opisthotonus and (ii) a moderate acute stage (PTD-MAS) when rats were reversed after
4.25 hours following seizure.
Combined Treatments of CET and PTD: To assess the potential synergistic
interactions between CET and TD, a subset of rats (CET-PTD) were exposed to the
PTD-EAS stage while they were exposed to 20% v/v ethanol. Following reversal, all PTD
rats were returned to normal rat chow and given a second thiamine reversal injection 24
hours later.
Pair fed (PF) control subjects also received thiamine deficient chow during this
symptom onset dependent 14-17 day period, however, they also received daily
injections of thiamine hydrochloride (0.4 mg/kg IP; Sigma-Aldrich, St. Louis, MO). To
mimic the anorexic effects of thiamine deficiency, PF animals were food deprived during
the period of weight loss prior to the onset of symptoms experienced by thiamine
deficient groups to match weight loss experienced by these subjects. All subjects were
given three weeks to recover and regain their free feeding weights prior to behavioral
testing. This paradigm has been previously described in work from this lab (Vetreno,
Klintsova, and Savage, 2011; Pitkin and Savage, 2000) and has been demonstrated to
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produce no differences, relative to untreated controls, in progenitor cell proliferation,
neurogenesis, (Vetreno, Klintsova, and Savage, 2011) or thiamine dependent enzymes
(Butterworth and Heroux, 1989).
Behavioral Assessments
Prior to behavioral testing all treatment groups underwent 7 days of food
restriction to achieve weights of 85 +/-5% free feeding weight, at which point delay
discounting testing commenced. Additionally, all animals were handled for five minutes a
day for 5 days prior to the initiation of testing and acclimated to BioServe (Flemington,
NJ, USA) Dustless Precision reward pellets (.5 g, unflavored) in their home cages during
this time.
Operant Delay Discounting and Reversal Learning
Operant boxes consisted of 12 large rodent testing chambers (Med Associates
Inc, St. Albans, VT, USA) measuring 55.9 cm X 55.9.cm X 35.6 cm. Each operant box
was contained within a sound and light attenuated chamber with a ventilation fan. Head
entry detectors were centered on the 35.6 cm side connected to external pellet
dispensers which deposited pellets in the head entry trough. Levers were located 3 cm
away from the head entry detector on either side at approximately 11 cm high. A single
house light was centered on the opposite wall 27 cm high.

Behavioral Testing
Initial and Reversal Delay Discounting
Following home cage exposure to reward pellets, subjects were trained on
programs of ascending difficulty; beginning with habituation, autoshaping, Fixed Ratio-1
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(FR1), Fixed Ratio-2 (FR2). Habituation consisted of 90-minute session during which the
rats were exposed to the operant boxes. The following day autoshaping was conducted;
this consisted of a 60 min session during which levers were randomly presented
individually and presses were rewarded until 60 trials were completed. Failure to lever
press during this 60 min task resulted in extended autoshape training done overnight.
The side that received the majority of presses during this procedure was deemed the
preferred side and designated the ‘delayed reward lever’ in later trials.
After completion of this task, rats were presented with a FR1 program during
which the house light would come on signaling the start of a trial. They then had to
place their head into the nose poke, breaking a photoreceptor beam to start the trial. At
that time the levers extended and the rat would have to press once to receive a 1 pellet
reward. The levers retracted and the house light went out for a 100 sec inter-trial interval
(ITI). In order to move on to the next phase, the rat had to have a side preference of less
than 75%.
If a rat had a side preference greater than 75%, remedial training was done
consisting of a FR1 task in which only one lever at a time was pseudo-randomly
presented. Completion of this task with choice behavior below the 75% ceiling moved
the animal on to FR1 where their performance was evaluated again to ascertain that
they would not exhibit a substantial side preference.
The FR2 program differed only in that the rat now had to make two lever
responses to receive the reward. The previously described 75% ceiling on side
preference remained in place and if the rat failed to perform below this criterion it was
again given remedial training consisting of an amended program that presented the
animals with a pseudo-randomized combination of 30 forced trails that presented the
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non-preferred lever and 30 random trials. Following this task, the rat was again
presented with the FR2 program and given another opportunity to reach criterion.
These pretraining programs culminated in a 0 Delay version of the Delay
Discounting program, during which reward discrimination was assessed. Once it was
established that each subject could discriminate reward magnitude, determined to be a
preference for a large, immediate (4 pellet) versus small, immediate (1 pellet) reward
75% of the time, they were exposed to the delay discounting program.
The delay discounting task was adapted from Mar and Robbins (2007) and
presented each subject with the opportunity to receive a small or large reward by
pressing one of two levers with predetermined designations. This was an ascending
delay paradigm beginning with a block at a 0 second delay and progressing to 10, 20,
40, and 60 seconds. Each block of delays consisted of 10 delay trials daily. The first
session began with 4 forced choice trials (2 forced trials occurred prior to subsequent
delay blocks) where levers were presented individually, which ensured that the subject
was exposed to both reward magnitudes.
Each delay block was initiated by the presentation of the house light, which
signaled the opportunity for the rat to nose poke, breaking a photoreceptor beam and
initiating the trial (failure to nose poke was coded as a ‘nose poke omission’). At this
point both levers would extend simultaneously, affording the animal the ability to press
either lever to obtain a reward. The rats had 10 seconds to respond by lever press, if
they failed to respond this would be counted as a “lever press omission”. Following a 6-s
consumption interim, the house light would go off for a 100 second inter-trial interval
prior to the initiation of the next trial. Once the subject reached behavioral stability,
deemed no differences in choice behavior greater than 25% for each consecutive delay
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for two three-session blocks, they progressed to the next phase of behavioral testing
(Reversal Learning).
Latency to nose poke and press levers were also recorded for later assessment
of individual/group differences in motivation. At the point of behavioral stability,
determined by no choice variation greater than 25% over the course of 6 consecutive
testing days when comparing across discrete delay intervals, the reversal phase
commenced the following day with delay times remaining consistent. The number of
sessions required to reach behavioral stability was recorded.
Importantly, which lever was pressed at each delay point was recorded allowing
for the assessment of changes in lever preference as a function of delay; determining
the subjective value of the reward for each rat as the time to receive said reward
increased incrementally across trials. This is the critical component of this task which
allows for interpretations regarding the impulsive choice behavior of each treatment
group.
Reversal Learning
Reversal learning was evaluated using the same program as the delay
discounting task, however reward contingencies were changed such that the lever
previously associated with receiving the large reward was now providing the smaller
reward. All other contingencies being equal, this forced the subjects to re-evaluate the
reward parameters of the task and alter behavioral responses accordingly. This
assessment continued until the subjects again reached behavioral stability, defined as
no choice variation greater than 25% over the course of 6 consecutive testing days when
comparing across discrete delay intervals. After the subject met this criterion, the
reversal phase was initiated. The number of sessions required to reach behavioral
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stability was recorded. or a 40 day testing ceiling, resulting in a post-reversal delay
discounting curve.
Nose poke and lever omissions were also recorded for later assessment of
individual/group differences in motivation. At the point of behavioral stability, determined
by no choice variation greater than 25% over the course of 6 consecutive testing days
when comparing across discrete delay intervals, the reversal phase commenced. The
number of sessions required to reach behavioral stability was recorded.

Behavioral Data Analysis
Behavioral data was analyzed using a two-way ANOVA followed by Dunnett’s
test in order to compare each group to controls, and LSD analysis for general group
comparisons.
Immunohistochemistry
Whole brains were extracted approximately 90 minutes following behavioral
testing. Rats were first euthanized with Sleep Away (0.5 mg/kg i.p. [26.0% sodium
pentobarbital in 7.8% isopropyl alcohol and 20.7% propylene glycol], Fort Dodge Animal
Health, Fort Dodge, IA) and transcardially perfused (Masterflux Cole-Parmer Instrument
Company, Trumpers Way, London) with a saline solution (9%) followed by a 4%
paraformaldehyde solution (in 0.1 M PBS). Brains were post fixed in 4%
paraformaldehyde followed by immersion into a 30% sucrose solution. Tissue was sliced
on a freezing sliding microtome (Leica SM2000R, Munich, Germany) at 40 uM and
stored in cryoprotectant at -20 degrees C in preparation for immunohistochemistry to
assess Arc and NeuN staining, and Cavalieri volumetric analysis.
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NeuN Staining
Slice selection commenced at the most anterior sample collected containing the
areas of interest (OFC, IL and PL, between 5.64 and 4.20 from Bregma, according to
Paxinos and Watson, 1982). Every 5th section was collected for staining. Sections were
rinsed 3 times in TBS for 5 minutes each at room temperature (RT). (Note: Adapted from
Cold Spring Harbor Protocols (2009); 50mM Tris-Cl and 150mM NaCl (pH 7.5 +/-.02)).
Subsequently, sections were rinsed in a 0.3 % Hydrogen Peroxide solution for 30
minutes at room temperature. Then sections were again rinsed 3 times for 5 minutes in
tris-buffered saline (TBS) at RT and blocked with Normal Horse Serum (NHS) (Vector
Labs (S-2000) Burlingame, CA, USA). Following this step, slices were rinsed for another
3 cycles in TBS for 5 minutes each at room temperature and incubated in NeuN primary
antibody monoclonal mouse anti-NeuN (Millipore (MAB337; Billerica, MA) for 48 hours at
4 degrees C (1:500). Sections were again rinsed 3 times in TBS for 5 minutes each, then
incubated in secondary antibody biotinylated horse anti-mouse IgG (Vector Labs; BA2001). Following this step, slices were incubated in ABC solution (ABC Elite kit standard
Vector Labs) at room temperature for 120 minutes then rinsed again for another 3 cycles
in TBS for 5 minutes each. Slices were then immersed in 3,3’-Diaminobenzidine (DAB
substrate kit, Sigma Aldrich) for visualization for approximately 3 minutes, a time period
determined by the color of the chromagen (DAB). Finally, slices were washed for
another three 10 minute cycles in TBS prior to mounting on slides. Slices were left to dry
overnight and coverslipped using Paramount (Fisher Chemicals, Hampton, NH).
Arc Staining
This procedure is adapted from Chia & Otto. (2013). Sections were washed 3
times in phosphate buffered saline (PBS) for 10 minutes each at room temperature and
subsequently blocked in 1% Bovine Serum Albumin (BSA) in PBS + (0.1% Triton-X) at
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room temperature for 1 hour. Following this step, slices were incubated in Primary rabbit
polyclonal Arc 1:1000 (Synaptic Systems, Goettingen, Germany). Thereafter, sections
were washed 3 times in PBS for 10 minutes and incubated in secondary solution
(Vector-Vectastain ABC kit (PK-6012)) anti-mouse at room temperature for 1 hour.
Afterwards, sections were again washed 3 times for 10 minutes each in PBS prior to
immersion in 3,3’-Diaminobenzidine (DAB substrate kit Sigma Aldrich St. Louis) solution
for visualization (approximately 3 minutes). Finally, slices were washed for another three
10 minute cycles in PBS prior to mounting on slides. Slices were left to dry overnight and
coverslipped using Paramount (Fisher Chemicals).
Cavalieri Volumetric Analysis (CVA)
Mounted 40 micron slices of NeuN stained tissue were examined using a Zeiss
Axioskop 2 plus microscope (Oberkochen, Germany) and CX9000 MBF Bioscience
camera (Willeston, VT), and analyzed using StereoInvestigator MBF Biosciences.
Sections were determined using a systematic sampling technique in which there was
analysis of equidistant sections commencing with the last section collected at the
confluence of the corpus callosum (Examples of region determination for volumetric
analysis of the OFC and PL/IL can be seen in Figure 2) in which the region of interest
last appears in a randomly chosen pre-collected series continuing for every 5th section
until 9 sections of orbitofrontal and 4 sections from the limbic cortex were analyzed for
each subject. These slices ranged from 2.52 to 4.20 from Bregma (Paxinos and Watson,
1982). CVA data was analyzed using a univariate ANOVA followed by a Dunnet’s test to
compare each group to controls, as well as LSD tests to compare across groups more
broadly.
Interventricular Distances (IVD) Measures
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In addition to quantitative analysis of cortical volumes, measures of
interventricular distances were taken as a metric of thalamic shrinkage (Robinson &
Mair, 1992; Hall & Savage, 2016). This was completed by measuring the distance from
the floor of the dorsal third ventricle to the top of the third ventricle at three locations (2.76mm, -3.24mm, -3.60mm from Bregma according to Paxinos and Watson, 1986)
thereby measuring the size of the thalamus. IVDs were analyzed using a univariate
ANOVA. Additionally, Pearson’s correlations were done to analyze the relationship
between IVDs and delay discounting behavior.
Cell Counting
Arc stained slices were counted at 7.6X magnification to evaluate cellular activity
in the medial and lateral orbitofrontal cortices as well as the prelimbic and infralimbic
regions. ROIs were .8 x .6 mm and omitted the neuron sparse plexiform layer of the
cortex (see Figure 3 for an exemplar). Slices were determined using the sampling
technique described in the CVA section and analyzed using ImageJ to automatically
count the regions depicted using a Nikon Optishot-2 microscope (Melville, NY) equipped
with an Infinity HD Lumenera camera (Nepan, ON, Canada). Counts were analyzed
based on anterior and posterior orientation using a repeated measures ANOVA and
Dunnett’s test as well as by individual slice using LSD analysis to compare across all
groups.
Results
Treatment Data:
Weight: There were overall differences in weights across groups (F(5,55)=5.286,
p<.05). PF subjects had a greater average body weight (544.79 g) than CET-TH (455.96
g) and CET-PTD (457.70 g) animals (p<.05) (Figure 4).
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Consumption: There were no significant differences in liquid consumption by
body weight across ethanol treated groups (CET; CET-Th; CET-PTD) (F(2, 29)=3.064,
p>.05) (Figure 5).
BEC: Blood ethanol concentration data analysis did not show any significant
differences across ethanol treated groups (Figure 6 A-C). All ethanol treated groups
were significantly higher than PF, the ethanol naïve control group (F(3,28)=28.321,
p<.001). In Month 1 all CET groups had means above 34 g/kg, this increased to means
above 45 g/kg in Month 2/3, rising again in Month 4 to means above 70 g/kg, at which
point there seems to be a ceiling effect with means topping out at above 85 mg/dl. This
effect of time was significant for all groups (F(3, 28)=28.321, p<.001).
Behavioral Data
Phase 1: Initial Acquisition (Delay Discounting)
There were significant group differences in the number of days required to reach
stability on the Delay Discounting task (Figure 7 A) (Main effect of treatment (F(5,
43)=3.33, p<.05). Dunnett’s test revealed that CET and CET-Th groups took significantly
longer than PF controls to reach criterion.
Exploratory Analysis
Exploratory post hoc LSD analysis showed differences between PF and CET
(p<.01), CET-TH (p<.01), CET-PTD (P<.05), and PTD-EAS (P<.05) illustrating that these
treatment groups took significantly more days to attain the behavioral stability criterion
than PF (Figure 7 A). Although PTD-MAS subjects did not differ significantly from PF
animals, they exhibited greater variability as expressed by their standard deviation.
Delay Discounting
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A significant overall effect of Treatment was seen (F(5,43)=2.21, p< 0.028). In
addition there was a general effect of Delay (F=4,172)=74.14, p<.001). There was a
significant Treatment x Delay interaction (F(20,172)=2.01, p<.05) (Figure 7 B). Dunnett’s
test revealed that there was a slight trend toward fewer delay lever choices in CET
treated groups (p=.080) and a significant reduction in PTD-MAS subjects (p<.05) when
compared to PF controls. Additionally, when examining discrete delay points there was
no significant difference at the 0 second time point (F(5, 49)=1.169, p>.05); at the 10
second delay there was no significant difference between groups (F(5, 49)=2.081,
p>.05). However there was a significant reduction in the preference for the delay lever in
PTD-MAS subjects at this time point as compared to controls using the Dunnett’s test
(p<.05); at the 20 second time point there were no significant differences overall
(F(5,49)=2.238, p>.05), however again Dunnett’s post hoc analysis revealed a significant
difference in PTD-MAS animals delay lever choices demonstrating a reduction as
compared to controls (p<.05); at the 40 second delay point there was a significant effect
of delay overall (F(5,49)=3.014, p<.05) as well as a significant reduction in delay lever
preference in PTD-MAS subjects as compared to PFs using the Dunnett’s test (p<.01);
finally, at the 60 second time point there was a significant effect of delay (F(5,49)=3.385,
p<.05) as well as a significant reduction in delay lever choice behavior in the PTD-MAS
(p<.01) and CET treated (p<.05) animals as compared to controls revealed by the
Dunnett’s test. There were no significant differences among other groups (p>.05).
Exploratory LSD:
Exploratory post hoc LSD (which allows for comparisons across all groups as
opposed to controls as in the Dunnett’s test) analysis shows differences between groups
at several delay intervals. PF rats are significantly different from rats in the CET and
CET-TH groups at 0-s delay (both F’s(1, 13)=5.879, p<.05). At the 10-s, 20-s and 40-s
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delay intervals only the PTD-MAS group differed from PF controls (F(1, 15)=5.907,
p’s<.05). Furthermore at the 60-delay interval both the CET and PTD-MAS groups were
different from PF controls (both F’s(1,15),(1,14))=5.880, p’s<.01). The PTD-MAS
subjects differ from PF controls starting at every protracted delay point, demonstrating a
more pronounced increase in impulsive choice behavior, as described in order of
increasing delay in the following paragraph. Neither the PTD-EAS or the CET-Th groups
differed from the PF control group at any delay interval. Because of the potential,
indicated by work from the lab previously discussed, for thiamine supplementation to
prevent the effects of CET and the potential differences between CET and PTD treated
groups, these metrics were also analyzed. Based on these analyses further testing may
be warranted. There were no significant differences among other treatment groups
(p>.05) (Figure 7 B).
Nose Poke Omissions
An additional metric observed, nose poke omissions, constitute the failure of an
animal to initiate the trial. There were no Treatment X Delay interactions (F(20,
168)=0.92, p<.3). There was an effect of Delay (F(4,268)=13.75, p<.05).There were no
significant differences across groups during the stability phase of the initial delay
discounting task (F(5,42)=.618,p>.05). (Figure 7 C and D)
Lever Omissions
A final metric, lever omissions, deemed a subject’s failure to press a lever and
thereby make a choice, showed no significant effects of Treatment during the last 6 days
for delay discounting (F(5,42)=1.471, p>.05). There was an effect of Delay
(F(4,168)=2.45, p<.05). There was no Treatment X Delay interaction (F(20, 168)=1.14,
p<.3) (Figure 7 E and F).
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Phase 2: Switched Contingencies (Reversal Learning)
There were no differences across treatment conditions during the Reversal
Learning Phase, defined as the first six days after the change in reward contingencies
(F(11.175)=.817, p>.05) (Figure 8 A and B).
Lever Omissions
There were no significant differences (5,42)=.269, p>.05) in lever omissions
across groups (Figure 8 C and D).
Nose Poke Omissions
There were no significant differences (F5,43)=1.45, p>.05) in nose poke
omissions across groups (Figure 8 E and F).

Task Reacquisition
Time to behavioral stability during the Reversal Delay Discounting was not
different across the treatment conditions (F(5,40)=1.609, p>.05) (Figure 9 A).
Additionally, Dunnett’s test revealed no significant differences across groups as
compared to PF controls (all p’s >.05).
Stable Performance:
Reversal Delay Discounting
The reversed delay discounting curves were attenuated by previous exposure to
the task resulting in an effect of delay (F(1.89, 77.57)=120.131, p<.001) (adjusted for
sphericity violation using Greenhouse-Guiesser) and no effect of treatment
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(F(5,41)=.757, p>.05). Dunnett’s test did not reveal any significant differences in
treatment groups as compared to PF controls (p>.05) (Figure 9 B)
Exploratory Analysis:
LSD analysis showed that there was a difference between PF and PTD-MAS
treatments at the 20 second time point, PTD-MAS rats were more impulsive than PF
subjects (F(1, 17 )=4.612, p<.05) (as noted in Figure 9 B).
Nose Poke Omissions
There were no significant Treatment differences in nose poke omissions across
groups during the stability phase of the reversal phase delay discounting task
(F(5,42)=1.45,p>.05). There were no Treatment X Delay interactions (F(10.17,
87.07)=1.08, P>.05). There was an effect of Delay (F(2.02, 87.007)=23.39, p<.0001).
(Figure 9 C and D).
Lever Omissions
Finally, there were no significant effects of treatment on lever omissions during
the reversal phase of discounting (F(5,42)=0.741,p>.05) There was also no effect of
Delay (F(3.03, 127.23)=1.41, p>.15) (Figure 9 E and F).
Histological Data
Interventricular Distances
There was no main effect of IVDs over all treatment groups (F(5,30)=2.07,p>.05).
(Figure 10). However, Dunnett’s test revealed that the IVD of CE T-PTD subjects were
significantly reduced as compared to PFs (p<.05).
Exploratory IVD and Behavioral Correlations
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Phase 1: Delay Discounting
Pearson’s r revealed no correlation between IVD and delay discounting behavior
at any time point. At 0 delay (r=-.234, n=25, p=.130); at 10 seconds (r=-.038, n= 25, p=
.429); at 20 seconds (r=-.047, n=25, p=.412); at 40 seconds (r=-.056, n=25, p=.395) and
at 60 seconds (r=-.054, n=25, p=.398). (Figure 11)
Phase 2: Reversal Learning
Pearson’s r revealed no correlation between IVD and delay discounting behavior
at any time point. At 0 delay (r=.319, n=25, p=.060); at 10 seconds (r=.012, n=25,
p=.478); at 20 seconds (r=-.066, n=25, p=.377); at 40 seconds (r=-.188, n=25, p=.184)
and at 60 seconds (r=-.090, n=25, p=.334). (Figure 12)
Cavalieri Volumetric Analysis
Orbitofrontal Cortex
There were no significant differences in cortical volume in the OFC across
groups (F(5,38)=.287, p=.919) (Figure 13).
Limbic Cortex
There were no significant differences in limbic volumes across groups in the
limbic cortex (F(5,38)=1.366, p=.259) (Figure 14). Dunnett’s test revealed no significant
differences in any groups as compared to PF controls (all p’s greater than .05).

Exploratory Analysis
Although there were no significant differences in orbitofrontal cortical volumes
across groups (all p’s>.05), LSD comparative analysis of limbic cortical volume revealed
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a significant increase in volume in CET subjects as compared to PF animals (p=.015).
Additionally, there was a trend (p=.06) toward larger limbic volumes in CET animals as
compared to those with thiamine supplementation (CET-TH) (Figure 14).
Cellular Activity
Medial OFC Activity
Cellular activity in the medial OFC (Figure 15 and 16) was not significantly
different overall across treatment groups (F(5, 33)=.332, p=.890). However, there was a
significant effect of anterior versus posterior regions which revealed higher Arc
immunoreactivity in the posterior region of the mOFC in all groups (F=1,33)=31.130,
p<.01). Dunnett’s test revealed that there were no significant differences in any
treatment groups as compared to PF controls (all p’s >.05).
Exploratory Analysis: Medial OFC
Slices were also analyzed individually to inform further analysis, those with
significant differences are reported here. For Slice 8: there were no overall differences
(F(5,1)=1.237, p=.166), again the PF subjects exhibited more cellular activity than CET
subjects (p=.042) and PTD-EAS animals (p=.042) (Figure 17). Additionally, for Slice 9
(Figure 18): there were no overall differences (F(5,1)=1.077, p=.394), yet there was still
a significant decrease in cellular activity in CET animals as compared to PFs (p=.037)
(Figures 17 and 18).
Lateral OFC Activity
Arc immunoreative cell counting revealed that there were no overall significant
differences in the lateral OFC across groups (F(5, 31)=.535, p=.748). However, there
were still differences across the anterior (Figure 19) versus posterior (Figure 20) axis
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with significantly greater overall Arc immunoreactivity in the posterior region (F=(5,
31)=28.688, p<.01). Dunnett’s test found that there were no significant differences in
treatment groups as compared to controls (all p’s >.05).

Exploratory Analysis: Lateral OFC
LSD analysis revealed that there were differences in cellular activity in posterior
slices, which will be discussed specifically. For Slice 7 (Figure 21): PF groups had more
active cells than CET (p=.018), PTD-EAS (p=.010), and PTD-MAS (p=.010), additionally
there was a trend toward more activity in PFs compared to both the CET-PTD subjects
(p=.082) and CET-TH animals (p=.055). For Slice 8 (Figure 22): there were no overall
significant differences [F(5,1)=2.011, p=.106] however PF subjects had significantly
more cellular activity than all treatment groups; CET (p=.020); CET-PTD (p=.034); CETTH (p=.019); PTD-EAS (p=.010); PTD-MAS (p=.014). Finally, in Slice 9 (Figure 23):
there were no overall significant differences (F(5,1), p=.085) though PF animals again
had higher cellular activity than other groups; CET-PTD (p=.007); CET-TH (p=.042);
PTD-EAS (p=.010); PTD-MAS (p=.014). In this case, there was also a trend toward PFs
having higher activity than CET subjects (p=.076).
Infralimbic Cortex
There were no overall differences in Arc immunoreactivity in the infralimbic cortex
(F(5,31)=.853, p=.524), however there were significant differences across the anteriorposterior axis; the anterior portions again had greater Arc immunoreactivity
(F(1,30)=14.869, p<.01). Dunnett’s test revealed that there were no significant
differences in treatment groups as compared to PFs (all p’s>.05) (Figures 24 and 25).
Exploratory Analysis: Infralimbic Activity
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In the case of the infralimbic cortex (Figure 26) in Slice 3: although there were no
overall differences (F(5,1)=.264, p=.264) there was significantly reduced activity in the
PTD-EAS subjects as compared to PFs (p=.038). In Slice 4 (Figure 27): there were no
significant overall differences across groups (F(5,1) =1.037, p=.414), however due to a
reduction of activity in PTD-EAS animals, and an increase in PTD-MAS subjects as
compared to PFs, there was a strong trend (p=.051) according to LSD analysis.
Prelimbic Cortex
There were no overall differences in Arc staining in the prelimbic cortex across
treatment groups (F(5,31)=504, p=.771). However, again there were significantly more
Arc positive cells in the anterior regions (F(1,30)=411,420, p=.019). Dunnett’s test
revealed no significant differences across groups when compared to PFs (all p’s>.05)
(Figures 28 and 29).
Exploratory Analysis: Prelimbic Activity
In the prelimbic cortex (Figure 30) there was again differential cellular activity in
the anterior region. In Slice 1: there were no overall differences (F(5,1)=1.086, p=.390),
and PF animals had significantly more cellular activity than PTD-MAS subjects (p=.046).
Discussion
The differential delay discounting curves demonstrated by CET and PTD-MAS
animals indicate that both of these treatments result in increased impulsive choice
behavior. Additionally, post reversal delay discounting curves demonstrated that this
behavior can be ‘trained out’ (reduced) with task exposure in CET subjects. That is to
say that, with practice, these impulsive choice tendencies can be ameliorated. An
important difference is that in PTD-MAS subjects there was an increase in impulsive
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behavior in the initial delay discounting task and this impulsivity may not be alleviated by
training during the post reversal phase as indicated by exploratory LSD analysis.
Another key point is that the animals exposed to chronic ethanol that received
thiamine supplementation (CET-Th) did not develop an impulsive phenotype.
Additionally, there is a non-significant, but visible, downward shift in the discounting
curve of subjects with milder thiamine deficiency (PTD-EAS) indicating a possibility that
mild thiamine deficiency could lead to a slightly more impulsive tendency, which
combined with CET, but not seen in CET-PTD, could result in significant differences in
impulsive choice behavior.
However, as illustrated in figures 11 and 12, in this study the CET-PTD subjects
demonstrated a unique phenotype with potential subpopulations with dissimilar
approaches to the task. This may be due to differences in neuropathology induced by
these comorbid treatments, an avenue for further investigation. Although there were not
statistically significant differences in CET-PTD subjects’ delay discounting curves from
those of PF subjects, this seems to have changed when examined with regard to IVD or
thalamic pathology. Subjects with reduced interventricular distance had a pattern of
slightly higher, though non-significant, levels of impulsivity than members of their group
whose IVDs were not two standard deviations below the mean of the PF group in the
initial delay discounting phase (Figure 11). This difference persisted during the reversal
phase as well (Figure 12), though there were no observable differences by the 60
second time point in this case.
Additionally, PTD-EAS subjects also exhibited this behavioral dichotomy when
compared based on IVD, illustrating a distinct difference in these two ‘subpopulations’
during the initial delay discounting phase (Figure 11) with those with thalamic pathology
being more impulsive. These observations suggest that thalamic damage is associated
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with the generation of the pervasive impulsive phenotype. Importantly, thalamic lesions
(a hallmark of WKS) which induce reductions in IVD are a direct consequence of
thiamine deficiency (for review see Savage, 2014), further implicating this nutritional
deficiency in the production of the impulsive phenotype.
Volumetric data indicated that there is a significant increase in the volume of the
limbic cortex, but not OFC, in CET animals compared to PF, based on LSD analysis.
This could be due to a compensatory or inflammatory response to chronic ethanol
treatment. Additionally, there was a trend toward larger limbic volumes in the CET group
as compared to CET-Th animals which should be noted. This may indicate that this
increase can be prevented with thiamine supplementation. Although there is established
evidence that chronic ethanol exposure can result in cortical shrinkage, there is also
differential vulnerability to ethanol exposure across brain regions (Archibald, FennemaNotestine, Gamst, Riley, Mattson, and Jernigan, 2001; for review see Butterworth, 2003;
for review see Goodlett, and Horn, 2001; for review see Sullivan and Pfefferbaum, 2005;
Volkow and Fowler, 2000; Ridderinkhof, Vlut, Bramlage, Spaan, Elton, Snel, and Band,
2002). Because volumetric analysis in this study encapsulated each region from anterior
to posterior as well as medial to lateral as a single data point, regional differences across
the tissue may not have been evident in the overall analysis. Therefore, further studies
could address the possibility that shrinkage in these regions is selective across these
dimensions, and if some regions increase in volume due to a compensatory mechanism
as may be suggested in our exploratory analysis in the case of CET subjects.
This point is furthered by the IHC data observing cellular activity using the
immediate early gene Arc, according to ANOVA (anterior-posterior differences) and
exploratory (LSD) analysis. Although these were low powered analyses, and are therefor
highly speculative, we observed a significant decrease in cellular activity in the posterior
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orbitofrontal cortex of all treatment groups compared to controls. In the limbic cortices,
however, differences were seen in the more anterior regions in the PTD-MAS animals as
compared to all other groups. This could be an artifact of region specific vulnerability that
could be explored in future work.
Importantly, however, this differential cellular activity is also consistent with past
literature, which informed the decision to conduct post hoc analyses in this study, that
indicates functional specificity within the anterior-posterior and medial-lateral axis of the
OFC. Studies have demonstrated that the medial OFC is implicated in the processing of
reward value, while the lateral portion is involved in punishment evaluation (for metaanalysis and review see Kringlebach and Rolls, 2004; O’Doherty, Kringlebach, Rolls,
Hornak, and Andrews, 2001). Differences in medial OFC activity demonstrated in the
most posterior, 8th and 9th, slices of the CET subjects, significantly less than PF, may
indicate a deficit or alteration in the processing of reward value. Also consistent with the
literature is the posterior location of these differences, as this region is implicated in the
processing of simple rewards (e.g., food) as opposed to the anterior region which
processes complex or learned rewards (e.g., cue, money) (for meta-analysis and review
see Kringlebach and Rolls, 2004; O’Doherty et al., 2001; De Araujo, Kringlebach, Rolls,
and McGlone, 2003b; De Araujo, Kringlebach, Rolls, McGlone, and Phillips, 2003c).
It is important to note that the Arc immunoreactivity indicating cellular activity
monitored in this study is specific to cellular activity at the 60 second time point, because
subjects were sacrificed at the culmination of their last day of stability (or at ceiling) 90
minutes after completion. This is the critical window for optimal Arc immunoreactivity
(Lonergan, Gafford, Jarome, and Helmsetter, 2010); however, it only demonstrates the
most recent activity. Because of the 60 second delay most recently presented to the
animals, there could have been reduced cellular activity inherent to that phase of the
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task, as 41% of neurons in the OFC fire in response to rewards received after a short
delay, whereas only 17% respond in anticipation of delayed rewards. This means that
there is inherently more activity for short delay rewards (Roesch, Taylor, and
Schoenbaum, 2006). However, at the 60 second time point there were no statistically
significant differences between groups indicating that this differential activity may be due
to reward processing differences rather than exposure to delay, because all subjects
were choosing the small delay for the immediate reward.
Because in this study we observed, according to limited exploratory analysis, that
there was significantly more cellular activity in the posterior three sections of the lateral
OFC, with the PF subjects displaying significantly more activity, there may be an
alteration in the processing of the aversive effects of delay (if considered punishing)
across all treatment groups.
Based on both behavioral and histological data, there is a possibility that
thiamine supplementation could slow or ameliorate the effects of chronic alcohol
exposure on choice impulsivity and potentially rescue some of the neuropathological
changes that occur in instances of chronic alcohol consumption. For example, there is a
visually evident, though non-significant, increase in impulsivity in the CET-Th group as
evidenced in the apparent increase in slope during delay discounting. This may indicate
that the progression of developing an impulsive phenotype is partially due to thiamine
deficiency because of the malabsorption of nutrients induced by chronic alcohol
consumption which seems to be slowed by thiamine supplementation. Bolstering this
argument is the apparent change in the behavior of the PTD-EAS subjects toward a
more impulsive phenotype, though not significantly different from PF animals.
Importantly, excessive thiamine deficiency at the level seen in the PTD-MAS animals not
only results in an impulsive phenotype, these subjects become more impulsive than
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those with chronic alcohol exposure alone and the ‘practice effects’ due to protracted
task exposure seen in CET subjects are absent from this group. This indicates that there
is a more persistent change in impulsive choice behavior that is dependent on thiamine
deficiency.
An additional point that warrants further investigation is the role of the limbic
cortex in the pervasive impulsive phenotype exhibited by the PTD-MAS group. This was
the only group that retained impulsive decision making behavior after excessive training.
They were also unique in their differential activity in the anterior portion of this region,
specifically the anterior prelimbic cortex. Because of this, the limbic cortical insults may
be critical in prolonged impulsive choice behavior. The differences in PTD-EAS cellular
activity in this region may have been driven by subjects in the low IVD ‘subpopulation’,
another point of further investigation.
The results observed in the CET-Th group demonstrated attenuated levels of
impulsivity and no significant differences from PF controls on neurohistological
assessments. This indicates a protective effect of thiamine supplementation in chronic
ethanol exposure. As discussed by Martin et al. (2003), chronic alcohol exposure can
culminate in an inadequate uptake of thiamine due to decreased absorption in the
gastrointestinal tract (Martin, Singleton and Hiller-Sturmhofel, 2003; for review see
Hoyumpa, 1980). Although in this study nutritional uptake was not measured (a potential
avenue for further investigation), there are two mechanisms involved. These were
discussed by Hoyumpa (1980); first a reduction in gastric absorption, and therefore a
potential for reduced thiamine intake into cells, and secondly impaired cellular utilization
of nutrients, in this case thiamine, may have been a factor in our CET groups. This may
have been prevented by thiamine supplementation in the CET-Th group, attenuating the
negative side effects of alcohol induced thiamine deficiency. Additionally, in animal
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studies it has been demonstrated that when thiamine is in low concentrations active
transport is necessary for thiamine to traverse the cellular membrane. In higher
concentrations, there is a chemical gradient which allows for passive transport of the
molecule into the cell (for review see Martin et al., 2003, Hoyumpa, 1980). This
differential mechanism may play a role in allowing for thiamine absorption in the CET-Th
subjects. However, this was not explored in this study and leaves another venue open
for investigation. Another factor may have been differences in food consumption across
both this group, as well as CET-PTD, as compared to PF subjects, who weighed
significantly more on average (Figure 4).
This research bolsters previous studies which have indicated that thiamine
supplementation may be beneficial in cases of chronic alcohol consumption. For
example, studies exploring the effect of thiamine supplementation administered to
chronically ethanol treated lab animals and alcoholic human patients have demonstrated
that this treatment ameliorated both metabolic and behavioral consequences of alcohol
induced thiamine deficiency (Lee, Tarter, Holburn, Price, Winestein and Martin, 1995;
Victor, Addams, and Collins, 1989). Additionally, experiments examining the effects of
thiamine supplementation on human subjects in recovery have demonstrated that the
most benefit is garnered from high dose thiamine treatment when considering working
memory performance (Ambrose, Bowden, and Whelan, 2001).
In line with these investigations, the use of thiamine supplementation as a
prophylactic treatment has been recommended in the past. It has been suggested that
preventative thiamine supplementation of 250 mg IM should be administered to at risk
patients (Cook and Thomson, 1997; Thomson and Cook, 1997; Cook, 2000; Thomson,
2000; Hope, Cook and Thomson, 1999). Prophylactic thiamine treatment has also been
suggested by Bligh and Madden (1983). Our current study bolsters this argument by
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demonstrating that thiamine supplementation concomitant with alcohol exposure
ameliorates the chronic alcohol induced impulsive phenotype as well as the
neuropathological changes seen in this treatment group.
This study also provides justification to investigate potential prophylactic
treatments for alcoholics or those in treatment to prevent further neurological insult.
Additionally, we have demonstrated separable, but linked, roles for the OFC and limbic
cortices that provide a foundation for further inquiry.
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Figure 1. Treatment and behavioral testing timeline depicting chronic ethanol and PTD
treatment, blood sample collection, recovery, and behavioral testing.

40

Figure 2. Example regions for Cavalieri Volumetric Analysis of the orbitofrontal cortex
(OFC), prelimbic (PL), and infralimbic (IL) cortices on representative NeuN stained
frontal tissue.
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Figure 3: Example regions for Arc immunoreactive cellular counting analysis of medial
and lateral OFC (mOFC and lOFC) as well as prelimbic and infralimbic cortex (PL and
IL). All regions were .8 x .6 mm.
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Figure 4. Average weights for PF and ethanol treated groups across the period of
ethanol treatment encompassing fade on and fade off demonstrate no differences. (n per
group: PF=8; CET=8; CET-TH=8; CET-PTD=9)
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Figure 5. A) Ethanol consumed in g/kg body weight for PF subjects and all CET groups.
B) Weeks 1-3 encompass the ‘Fade On’ portion of CET titrating up from 0 (6%, 9%, 12%
EtOH), C) Weeks 29-31 are the ‘Fade Off’ of treatment prior to recovery. (n per group:
PF=8; CET=8; CET-TH=8; CET-PTD=9)
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Figure 6. BEC levels measured at months 1, 2/3, 4, and 6 were not different as a
function of group within CET treated animals. However, the BECs of rats exposed to
EtOH increased across time. The BECs from these groups were significantly above PF
rats given water. (n per group: PF=8; CET=8; CET-TH=8; CET-PTD=9)
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A. Days to Reach Criterion

C. Nose Poke Omissions by Delay

E. Lever Omissions by Delay

B. Delayed Discounting Curve (Last 6 Days)

D. Nose Poke Omission Averages

F. Lever Omission Averages

Figure 7. A). Days to reach behavioral stability during initial delay discounting phase. B)
Delay lever choice behavior (%) across increasing delays (s) C) Nose poke omissions
across increasing time points. D) Average nose poke omissions during the last 6 days of
delay discounting. E) Lever omissions by delay. F) Average lever omissions. (n per
group: PF=8; CET=8; CET-TH=8; CET-PTD=7; PTD-EAS=9; PTD-MAS=9)
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Figure 8. A). Days to reach behavioral stability. B) Delay lever choice behavior (%)
across increasing delays (s) (*) indicate significant differences from PF at a particular
time point). C.) Lever omissions by delay D.) Average lever omissions E.) Nose poke
omissions across increasing time points illustrating that PTD-MAS and CET-Th rats are
less likely to fail to initiate trials F). Average nose poke omissions during reversal
learning phase. (n per group: PF=8; CET=8; CET-TH=8; CET-PTD=7; PTD-EAS=8;
PTD-MAS=10)
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A. Days to Reach Reversal Criterion

C. Nose Poke Omissions by Delay

E. Lever Omissions by Delay

B. Post-Reversal Delay Discounting Curve

D. Nose Poke Omission Averages

F. Lever Omission Averages

Figure 9. A). Days to reach reversal phase delay discounting stability criterion (ie:
behavioral stability). B) Delay lever choice behavior (%) across increasing delays (s) (*
indicate significant differences from PF at a specific time point). C) Nose poke omissions
across increasing time points. D) Average nose poke omissions during the last 6 days of
delay discounting. E.) Lever omissions as delay to reward increases F.) Average lever
omissions by treatment. (n per group: PF=8; CET=7; CET-TH=7; CET-PTD=7; PTDEAS=9; PTD-MAS=9)
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Figure 10. Average interventricular distance demonstrating reductions (n.s.) in PTD-EAS
and PTD-MAS treatment groups and significant reductions in CET-PTD rats. (n per
group: PF=6; CET=7; CET-TH=3; CET-PTD=6; PTD-EAS=7; PTD-MAS=7)
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Figure 11. Initial phase delay discounting curves with PTD subjects parsed based on
interventricular distance (IVD). Groups designated ‘sm’ have IVDs 2 standard deviations
below the mean of PF treated animals. (n per group: PF=8; CET=7; CET-TH=7; CETPTD=3; PTD-EAS=6; PTD-MAS=7; C-P Sm=3; EAS Sm=2; MAS Sm=2)
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Figure 12. Reversal phase delay discounting curves with PTD subjects parsed based on
interventricular distance. Groups designated ‘sm’ have IVDs 2 standard deviations below
the mean of PF treated animals. (n per group: PF=8; CET=7; CET-TH=7; CET-PTD=3;
PTD-EAS=6; PTD-MAS=7; C-P (CET-PTD) Sm=3; EAS Sm=2; MAS Sm=2)
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Figure 13. Cavalieri volumetric analysis of orbitofrontal cortex volumes demonstrating no
differences across groups. (n per group: PF=7; CET=7; CET-TH=6; CET-PTD=7; PTDEAS=8; PTD-MAS=9)
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Figure 14. Cavalieri volumetric analysis of limbic cortex volume demonstrating increased
volume in the CET group as compared to PF animals. (n per group: PF=7; CET=6; CETTH=7; CET-PTD=7; PTD-EAS=8; PTD-MAS=9)
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Figure 15. Average anterior Arc immunoreactive cells in the antero-medial orbitofrontal
cortex. (n per group: PF=5; CET=5; CET-TH=4; CET-PTD=4; PTD-EAS=5; PTDMAS=4)
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Figure 16. Average Arc immunoreactivity in postero-medial orbitofrontal cortex neurons.
(n per group: PF=5; CET=5; CET-TH=4; CET-PTD=4; PTD-EAS=5; PTD-MAS=4)
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Figure 17. Arc immunoreactive cell counts indicating higher cellular activity in PFs as
compared to CET and PTD-EAS subjects. (n per group: PF=5; CET=6; CET-TH=7; CETPTD=5; PTD-EAS=7; PTD-MAS=7)
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Figure 18. Active cell counts demonstrating decreased cellular activity in CET subjects
as compared to PFs. (n per group: PF=5; CET=5; CET-TH=5; CET-PTD=6; PTDEAS=8; PTD-MAS=6)
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Figure 19. Average antero-lateral orbitofrontal cortex Arc immunoreactivity. (n per group:
PF=4; CET=3; CET-TH=3; CET-PTD=4; PTD-EAS=7; PTD-MAS=4)
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Figure 20. Average postero-lateral orbitofrontal cortical Arc immunoreactivity. (n per
group: PF=4; CET=3; CET-TH=3; CET-PTD=4; PTD-EAS=7; PTD-MAS=4)
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Figure 21. Cellular activity counts demonstrating higher activity in PF animals as
compared to other groups. (n per group: PF=5; CET=5; CET-TH=5; CET-PTD=6; PTDEAS=8; PTD-MAS=7)
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Figure 22. Counts of active cells demonstrating that PFs had higher cellular activity as
compared to all other groups. (n per group: PF=5; CET=6; CET-TH=5; CET-PTD=6;
PTD-EAS=7; PTD-MAS=7)
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Figure 23. Counts of active cells demonstrating that PFs had higher cellular activity as
compared to all other groups. (n per group: PF=5; CET=3; CET-TH=5; CET-PTD=6;
PTD-EAS=8; PTD-MAS=6)
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Figure 24. Average anterior infralimbic cortical Arc immunoreactivity. (n per group: PF=2;
CET=2; CET-TH=2; CET-PTD=3; PTD-EAS=3; PTD-MAS=5)
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Figure 25. Average posterior infralimbic Arc immunoreactivity. (n per group: PF=2;
CET=2; CET-TH=2; CET-PTD=3; PTD-EAS=3; PTD-MAS=5)
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Figure 26. Counts of active cells demonstrating that PFs had significantly more cellular
activity than PTD-EAS subjects. (n per group: PF=5; CET=6; CET-TH=5; CET-PTD=5;
PTD-EAS=7; PTD-MAS=6)
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Figure 27. Active (Arc positive) cell counts demonstrating that PTD-EAS animals differed
from PTD-MAS animals as they decreased and increased as compared to controls,
respectively. (n per group: PF=5; CET=6; CET-TH=5; CET-PTD=6; PTD-EAS=8; PTDMAS=7)
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Figure 28. Average anterior prelimbic Arc immunoreactivity. (n per group: PF=4; CET=5;
CET-TH=4; CET-PTD=5; PTD-EAS=6; PTD-MAS=5)
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Figure 29. Average posterior prelimbic Arc immunoreactivity. (n per group: PF=4;
CET=5; CET-TH=4; CET-PTD=5; PTD-EAS=6; PTD-MAS=5)
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Figure 30. Active cell counts demonstrating that PF subjects had significantly more
activity than PTD-MAS animals. (n per group: PF=5; CET=5; CET-TH=5; CET-PTD=5;
PTD-EAS=8; PTD-MAS=6)
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